Fat oxidation, hormonal and plasma metabolite kinetics during a submaximal incremental test in lean and obese adults

Stefano Lanzi, Franco Codecasa, Mauro Cornacchia, Sabrina Maestrini, Alberto Salvadori, Amelia Brunani, Davide Malatesta, Stefano Lanzi, Franco Codecasa, Mauro Cornacchia, Sabrina Maestrini, Alberto Salvadori, Amelia Brunani, Davide Malatesta

Abstract

This study aimed to compare fat oxidation, hormonal and plasma metabolite kinetics during exercise in lean (L) and obese (O) men. Sixteen L and 16 O men [Body Mass Index (BMI): 22.9 ± 0.3 and 39.0 ± 1.4 kg · m(-2)] performed a submaximal incremental test (Incr) on a cycle-ergometer. Fat oxidation rates (FORs) were determined using indirect calorimetry. A sinusoidal model, including 3 independent variables (dilatation, symmetry, translation), was used to describe fat oxidation kinetics and determine the intensity (Fat(max)) eliciting maximal fat oxidation. Blood samples were drawn for the hormonal and plasma metabolite determination at each step of Incr. FORs (mg · FFM(-1) · min(-1)) were significantly higher from 20 to 30% of peak oxygen uptake (VO2peak) in O than in L and from 65 to 85% VO2peak in L than in O (p ≤ 0.05). FORs were similar in O and in L from 35 to 60% VO2peak. Fat max was 17% significantly lower in O than in L (p<0.01). Fat oxidation kinetics were characterized by similar translation, significantly lower dilatation and left-shift symmetry in O compared with L (p<0.05). During whole exercise, a blunted lipolysis was found in O [lower glycerol/fat mass (FM) in O than in L (p ≤ 0.001)], likely associated with higher insulin concentrations in O than in L (p<0.01). Non-esterified fatty acids (NEFA) were significantly higher in O compared with L (p<0.05). Despite the blunted lipolysis, O presented higher NEFA availability, likely due to larger amounts of FM. Therefore, a lower Fat(max), a left-shifted and less dilated curve and a lower reliance on fat oxidation at high exercise intensities suggest that the difference in the fat oxidation kinetics is likely linked to impaired muscular capacity to oxidize NEFA in O. These results may have important implications for the appropriate exercise intensity prescription in training programs designed to optimize fat oxidation in O.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Mean respiratory exchange ratio (RER)…
Figure 1. Mean respiratory exchange ratio (RER) values represented as a function of exercise intensity [absolute power output (A) and % of peak oxygen uptake () (B)] determined during the submaximal incremental test in lean (L: blue, n = 16) and obese (O: red, n = 16) individuals.
Values are the means±SE. * p≤0.05 for differences with lean; † p≤0.05 for significant group interaction effect.
Figure 2. Mean whole-body fat oxidation kinetics…
Figure 2. Mean whole-body fat oxidation kinetics in absolute [g.min−1 (A and B) and mg.FFM−1.min−1 (C)] and relative [% of maximal fat oxidation (MFO) (D)] values determined with the sinusoidal (SIN) model and during the submaximal incremental test in lean (L: blue, n = 16) and obese (O: red, n = 16) individuals.
Values are the means±SE. : peak oxygen uptake. * p≤0.05 for differences with lean; † p≤0.05 for significant group interaction effect.
Figure 3. Mean non-esterified fatty acid (NEFA)…
Figure 3. Mean non-esterified fatty acid (NEFA) concentrations (A) and mean glycerol concentrations (B) divided by fat mass (C) during the submaximal incremental test in lean (L: blue, n = 16) and obese (O: red, n = 14) individuals.
Values are the means±SE. PPO: peak power output. * p≤0.05 for differences with lean; † p≤0.05 for significant group interaction effect.
Figure 4. Mean epinephrine (A), norepinephrine (B),…
Figure 4. Mean epinephrine (A), norepinephrine (B), atrial natriuretic peptide (C) and insulin (D) concentrations during the submaximal incremental test in lean (L: blue, n = 16) and obese (O: red, n = 14) individuals.
Values are the means±SE. PPO: peak power output. * p≤0.05 for differences with lean; † p≤0.05 for significant group interaction effect.
Figure 5. Mean glycerol concentrations (A) divided…
Figure 5. Mean glycerol concentrations (A) divided by fat mass (B), mean non-esterified fatty acid (NEFA) concentrations (C) and whole-body fat oxidation kinetics in relative (D) [% of maximal fat oxidation (MFO)] values determined with the sinusoidal (SIN) model during the submaximal incremental test in lean (L: dark and light blue) and obese (O: dark and light red) individuals.
In the sub-groups matched for aerobic fitness, O present similar MFO (O: 6.3±0.6; L: 5.5±0.4 mg.FFM−1.min−1), left-shifted (O: 0.9±0.1; L: 1.2±0.1 for symmetry; p<0.05) and less dilated (O: –0.1±0.1; L: 0.3±0.1 for dilatation; p<0.05) curve, lower Fatmax (O: 46.5±5.0; L: 55.8±2.6 %) and lower Fatmax zone (O: 25.8±2.3; L: 30.1±1.2 %) although non-significant as a consequence of the small sample size. Values are the means±SE. PPO: peak power output. * p≤0.05 for differences between sub-groups; † p≤0.05 for significant group interaction effect between sub-groups; $ for significant group effect between sub-groups [2-way repeated-measures mixed design ANOVA (exercise intensity x group) followed by contrasts].

References

    1. Houmard JA, Pories WJ, Dohm GL (2012) Severe obesity: evidence for a deranged metabolic program in skeletal muscle? Exerc Sport Sci Rev 40: 204–210.
    1. Houmard JA (2008) Intramuscular lipid oxidation and obesity. Am J Physiol Regul Integr Comp Physiol 294: R1111–1116.
    1. Bordenave S, Metz L, Flavier S, Lambert K, Ghanassia E, et al. (2008) Training-induced improvement in lipid oxidation in type 2 diabetes mellitus is related to alterations in muscle mitochondrial activity. Effect of endurance training in type 2 diabetes. Diabetes Metab 34: 162–168.
    1. Venables MC, Jeukendrup AE (2008) Endurance training and obesity: effect on substrate metabolism and insulin sensitivity. Med Sci Sports Exerc 40: 495–502.
    1. Perez-Martin A, Dumortier M, Raynaud E, Brun JF, Fedou C, et al. (2001) Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab 27: 466–474.
    1. Goodpaster BH, Wolfe RR, Kelley DE (2002) Effects of obesity on substrate utilization during exercise. Obes Res 10: 575–584.
    1. Larsen S, Ara I, Rabol R, Andersen JL, Boushel R, et al. (2009) Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes? Diabetologia 52: 1400–1408.
    1. Mittendorfer B, Fields DA, Klein S (2004) Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise. Am J Physiol Endocrinol Metab 286: E354–362.
    1. Thyfault JP, Kraus RM, Hickner RC, Howell AW, Wolfe RR, et al. (2004) Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol Endocrinol Metab 287: E1076–1081.
    1. Ara I, Larsen S, Stallknecht B, Guerra B, Morales-Alamo D, et al. (2011) Normal mitochondrial function and increased fat oxidation capacity in leg and arm muscles in obese humans. Int J Obes (Lond) 35: 99–108.
    1. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, et al. (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43: 1334–1359.
    1. Frayn KN (2010) Fat as a fuel: emerging understanding of the adipose tissue-skeletal muscle axis. Acta Physiol (Oxf) 199: 509–518.
    1. De Glisezinski I, Crampes F, Harant I, Berlan M, Hejnova J, et al. (1998) Endurance training changes in lipolytic responsiveness of obese adipose tissue. Am J Physiol 275: E951–956.
    1. Mauriege P, Despres JP, Prud'homme D, Pouliot MC, Marcotte M, et al. (1991) Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res 32: 1625–1633.
    1. Stich V, De Glisezinski I, Crampes F, Hejnova J, Cottet-Emard JM, et al. (2000) Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol Regul Integr Comp Physiol 279: R499–504.
    1. Achten J, Gleeson M, Jeukendrup AE (2002) Determination of the exercise intensity that elicits maximal fat oxidation. Med Sci Sports Exerc 34: 92–97.
    1. Brun JF, Malatesta D, Sartorio A (2012) Maximal lipid oxidation during exercise: A target for individualizing endurance training in obesity and diabetes? J Endocrinol Invest 35: 686–691.
    1. World Health Organisation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF Consultation. 1–50 p.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.
    1. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60: 1327–1332.
    1. Piccoli A, Brunani A, Savia G, Pillon L, Favaro E, et al. (1998) Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metab Disord 22: 97–104.
    1. Baumgartner RN, Ross R, Heymsfield SB (1998) Does adipose tissue influence bioelectric impedance in obese men and women? J Appl Physiol 84: 257–262.
    1. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628–634.
    1. Cheneviere X, Malatesta D, Peters EM, Borrani F (2009) A mathematical model to describe fat oxidation kinetics during graded exercise. Med Sci Sports Exerc 41: 1615–1625.
    1. Mogensen M, Bagger M, Pedersen PK, Fernström M, Sahlin K (2006) Cycling efficiency in humans is related to low UCP3 content and to type I fibres but not to mitochondrial efficiency. J Physiol 571: 669–681.
    1. Stich V, de Glisezinski I, Galitzky J, Hejnova J, Crampes F, et al. (1998) Endurance training increases the beta-adrenergic lipolytic response in subcutaneous adipose tissue in obese subjects. Int J Obes Relat Metab Disord 23: 374–381.
    1. Wong T, Harber V (2006) Lower excess postexercise oxygen consumption and altered growth hormone and cortisol responses to exercise in obese men. J Clin Endocrinol Metab 91: 678–686.
    1. Day JR, Rossiter HB, Coats EM, Skasick A, Whipp BJ (2003) The maximally attainable VO2 during exercise in humans: the peak vs. maximum issue. J Appl Physiol (1985) 95: 1901–1907.
    1. Wood RE, Hills AP, Hunter GR, King NA, Byrne NM (2010) Vo2max in overweight and obese adults: do they meet the threshold criteria? Med Sci Sports Exerc 42: 470–477.
    1. Kanaley JA, Weatherup-Dentes MM, Alvarado CR, Whitehead G (2001) Substrate oxidation during acute exercise and with exercise training in lean and obese women. Eur J Appl Physiol 85: 68–73.
    1. Nordby P, Saltin B, Helge JW (2006) Whole-body fat oxidation determined by graded exercise and indirect calorimetry: a role for muscle oxidative capacity? Scand J Med Sci Sports 16: 209–214.
    1. De Glisezinski I, Larrouy D, Bajzova M, Koppo K, Polak J, et al. (2009) Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue. J Physiol 587: 3393–3404.
    1. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. Faseb J 14: 1345–1351.
    1. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, et al. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594–600.
    1. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, et al. (1997) Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 15: 1695–1699.
    1. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, et al. (2001) The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 42: 536–544.
    1. Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60: 2441–2449.
    1. Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277: E1130–1141.
    1. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA (2000) Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039–1044.
    1. Braun B, Sharoff C, Chipkin SR, Beaudoin F (2004) Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol 97: 991–997.
    1. van Loon LJ (2004) Use of intramuscular triacylglycerol as a substrate source during exercise in humans. J Appl Physiol 97: 1170–1187.
    1. Solomon TP, Sistrun SN, Krishnan RK, Del Aguila LF, Marchetti CM, et al. (2008) Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults. J Appl Physiol 104: 1313–1319.
    1. van Aggel-Leijssen DP, Saris WH, Hul GB, van Baak MA (2001) Short-term effects of weight loss with or without low-intensity exercise training on fat metabolism in obese men. Am J Clin Nutr 73: 523–531.
    1. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37: 287–301.
    1. Romijn JA, Coyle EF, Hibbert J, Wolfe RR (1992) Comparison of indirect calorimetry and a new breath 13C/12C ratio method during strenuous exercise. Am J Physiol 263: E64–71.

Source: PubMed

3
Subskrybuj